• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
New administrative data in Truveta Data and features in Truveta Studio help researchers accelerate scientifically rigorous research

New administrative data in Truveta Data and features in Truveta Studio help researchers accelerate scientifically rigorous research

by Michael Simonov, MD | Mar 26, 2025 | News

Today, we’re excited to celebrate our latest innovation in Truveta across both Truveta Data and Truveta Studio. Truveta Data has expanded to include new administrative data to enable more comprehensive analyses of healthcare outcomes and patient journeys. We...
Truveta supports regulatory submissions to the FDA and global regulatory authorities

Truveta supports regulatory submissions to the FDA and global regulatory authorities

by Truveta staff | Jun 17, 2024 | Data, News, Technology

Truveta now offers regulatory and audit capabilities to support our customers for real-world evidence (RWE) submissions to the Food and Drug Administration (FDA) and other global regulatory authority decisions. These regulatory grade capabilities advance Truveta’s...
Raising the bar: Truveta’s approach to real-world data quality

Raising the bar: Truveta’s approach to real-world data quality

by Truveta staff | Jan 31, 2024 | Data

Clinical trials and registries have traditionally been the gold standard for high-quality healthcare data, offering complete longitudinal records across data domains in a clean, analysis-ready format. However, achieving this level of quality involves significant...

Share this


Recent posts

  • Truveta leads a new era in cancer research with the most complete, representative, and timely real-world data on all cancers
  • Top 5 takeaways from Truveta Symposium 2025
  • Women’s health: Pain medication remains rare for women receiving IUDs

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Get started

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Interested in learning more?

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice